Merit Medical Systems Inc revenue by segment MMSI

Annual Quarterly

Merit Medical Systems Inc splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was Cardiovascular at $1.4 billion, 95% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Peripheral Intervention at $579.8 million, 38% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016
Revenue	1,611	1,516	1,357	1,257	1,151	1,075	964	995	883	—	—
Operating segments
Cardiovascular	—	1,443 +10.9% share 95.2%	1,302 +6.7% share 96.0%	1,221 +9.2% share 97.1%	1,118 +7.2% share 97.2%	1,043 +11.7% share 97.1%	934 -2.8% share 96.9%	961 +13.1% share 96.6%	849 +21.2% share 96.2%	701	—
Endoscopy	—	73 +33.0% share 4.8%	55 +48.8% share 4.0%	37 +12.4% share 2.9%	33 +3.9% share 2.8%	32 +6.2% share 2.9%	30 -12.4% share 3.1%	34 +1.8% share 3.4%	33 +22.2% share 3.8%	27	—
Sales mix
Peripheral Intervention	—	580 +8.8% share 38.3%	533 +10.2% share 39.3%	483 +9.9% share 38.4%	440 +8.6% share 38.2%	405 +18.6% share 37.7%	342 -2.7% share 35.4%	351 share 35.3%	—	—	—
Cardiac Intervention	—	449 +21.7% share 29.6%	369 +3.4% share 27.2%	357 +3.9% share 28.4%	343 +7.0% share 29.8%	321 +14.6% share 29.8%	280 share 29.0%	—	—	—	—
Custom Procedural Solutions	—	209 +4.6% share 13.8%	200 +3.3% share 14.7%	194 +1.9% share 15.4%	190 -1.9% share 16.5%	194 -4.6% share 18.0%	203 share 21.1%	—	—	—	—
OEM	—	205 +2.5% share 13.5%	200 +7.0% share 14.7%	187 +28.9% share 14.9%	145 +17.4% share 12.6%	124 +12.5% share 11.5%	110 -6.9% share 11.4%	118 share 11.8%	—	—	—
Endoscopy Devices	—	73 +33.0% share 4.8%	55 +48.8% share 4.0%	37 +12.4% share 2.9%	33 +3.9% share 2.8%	32 +6.2% share 2.9%	30 -12.4% share 3.1%	34 +1.8% share 3.4%	33 +22.2% share 3.8%	27	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: MMSI (Nasdaq)
Fiscal year ends: December 31
Incorporated in: UT
Headquarters: South Jordan, UT
SEC filer status: Large accelerated filer
SEC CIK: 856982

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.